Wall Street Experts
ver. ZuMIgo(08/25)
Armata Pharmaceuticals, Inc.
Rachunek Zysków i Strat
Przychody TTM (mln): 2
EBIT TTM (mln): -32
index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
15 |
16 |
17 |
18 |
19 |
20 |
21 |
22 |
23 |
24 |
Rok finansowy |
1996 |
1997 |
1998 |
1999 |
2000 |
2001 |
2002 |
2003 |
2004 |
2005 |
2006 |
2007 |
2008 |
2012 |
2013 |
2014 |
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
Przychód (mln) |
2 |
1 |
7 |
7 |
11 |
19 |
19 |
14 |
10 |
7 |
10 |
10 |
9 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
4 |
6 |
5 |
Przychód Δ r/r |
0.0% |
-60.9% |
700.0% |
-5.6% |
67.7% |
65.6% |
2.4% |
-27.2% |
-31.4% |
-28.8% |
43.5% |
4.7% |
-15.6% |
-92.4% |
-51.1% |
25.8% |
16.1% |
-45.3% |
-55.8% |
-100.0% |
0.0% |
inf% |
443.6% |
23.1% |
-17.8% |
Marża brutto |
182.6% |
277.8% |
122.2% |
123.5% |
115.6% |
100.0% |
100.0% |
100.0% |
100.0% |
100.0% |
100.0% |
100.0% |
100.0% |
100.0% |
100.0% |
100.0% |
100.0% |
100.0% |
100.0% |
0.0% |
-inf% |
-1655.0% |
-347.4% |
83.8% |
78.5% |
EBIT (mln) |
-12 |
-15 |
-9 |
-11 |
-15 |
-29 |
-23 |
-14 |
-15 |
-19 |
-37 |
-17 |
-21 |
-4 |
-15 |
-14 |
-10 |
-23 |
-16 |
-13 |
-20 |
-22 |
-24 |
-37 |
-41 |
EBIT Δ r/r |
0.0% |
23.1% |
-38.9% |
22.0% |
37.9% |
86.9% |
-20.5% |
-39.3% |
9.9% |
27.5% |
89.8% |
-54.9% |
27.9% |
-81.0% |
272.4% |
-5.8% |
-27.5% |
128.6% |
-30.9% |
-22.5% |
57.7% |
9.3% |
10.4% |
55.1% |
10.7% |
EBIT (%) |
-526.1% |
-1655.6% |
-126.4% |
-163.2% |
-134.2% |
-151.5% |
-117.6% |
-98.1% |
-157.2% |
-281.5% |
-372.4% |
-160.2% |
-242.8% |
-606.0% |
-4611.1% |
-3449.9% |
-2153.1% |
-8991.5% |
-14048.7% |
0.0% |
0.0% |
-2623.0% |
-532.5% |
-670.8% |
-902.8% |
Koszty finansowe (mln) |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
1 |
0 |
1 |
0 |
0 |
0 |
0 |
3 |
0 |
0 |
0 |
0 |
0 |
1 |
1 |
0 |
0 |
3 |
EBITDA (mln) |
3 |
-14 |
-8 |
-7 |
17 |
-22 |
-15 |
-1 |
-14 |
-15 |
-11 |
-12 |
-3 |
-4 |
26 |
-51 |
-20 |
-8 |
-6 |
-8 |
-18 |
-20 |
-23 |
-36 |
-40 |
EBITDA(%) |
143.5% |
-1600.0% |
-113.9% |
-98.5% |
145.3% |
-115.5% |
-76.9% |
-8.4% |
-139.9% |
-222.2% |
-115.8% |
-112.8% |
-35.1% |
-607.8% |
7894.8% |
-12511.2% |
-4112.6% |
-3251.2% |
-5389.6% |
0.0% |
0.0% |
-2483.5% |
-506.2% |
-654.6% |
-881.4% |
Podatek (mln) |
26 |
14 |
9 |
27 |
48 |
27 |
24 |
15 |
14 |
19 |
34 |
16 |
21 |
-3 |
43 |
-37 |
-0 |
-1 |
-1 |
-0 |
-0 |
1 |
0 |
-0 |
0 |
Zysk Netto (mln) |
-26 |
-14 |
-9 |
-27 |
-48 |
-27 |
-24 |
-15 |
-14 |
-19 |
-34 |
-16 |
-21 |
-1 |
-58 |
23 |
-1 |
-19 |
-13 |
-12 |
-19 |
-23 |
-23 |
-37 |
-69 |
Zysk netto Δ r/r |
0.0% |
-45.4% |
-38.7% |
206.9% |
78.5% |
-43.0% |
-12.5% |
-37.6% |
-3.9% |
34.7% |
77.0% |
-52.6% |
28.5% |
-94.6% |
5162.3% |
-139.6% |
-102.2% |
3550.8% |
-31.9% |
-5.7% |
57.1% |
19.9% |
1.8% |
58.9% |
87.2% |
Zysk netto (%) |
-1130.4% |
-1577.8% |
-120.8% |
-392.6% |
-417.9% |
-143.9% |
-122.9% |
-105.4% |
-147.7% |
-279.3% |
-344.6% |
-156.1% |
-237.7% |
-167.2% |
-17972.6% |
5650.1% |
-108.6% |
-7245.4% |
-11163.5% |
0.0% |
0.0% |
-2772.2% |
-519.0% |
-669.7% |
-1524.5% |
EPS |
-7924.41 |
-3515.72 |
-1633.19 |
-4149.83 |
-6312.01 |
-3092.77 |
-2596.63 |
-1290.16 |
-12561.23 |
-15697.47 |
-24313.3 |
-6842.17 |
-7270.18 |
-161.76 |
-4040.33 |
589.4 |
-13.35 |
-268.06 |
-28.14 |
-8.9 |
-2.43 |
-1.39 |
-0.96 |
-1.08 |
-1.91 |
EPS (rozwodnione) |
-7924.41 |
-3515.72 |
-1633.19 |
-4149.83 |
-6312.01 |
-3092.77 |
-2596.63 |
-1290.16 |
-12561.23 |
-15697.47 |
-24313.3 |
-6842.17 |
-7270.18 |
-161.76 |
-4040.33 |
-326.2 |
-13.35 |
-268.06 |
-27.34 |
-8.9 |
-2.43 |
-1.39 |
-0.96 |
-1.08 |
-1.91 |
Ilośc akcji (mln) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
8 |
16 |
24 |
34 |
36 |
Ważona ilośc akcji (mln) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
8 |
16 |
24 |
34 |
36 |
Waluta |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |